Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alsenz

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Complement and Inflammation|January 1, 1989
Cell surface proteins reacting with activated complement componentsJ D Becherer, J Alsenz, C Servis, et al.
The Biochemical Journal|December 15, 1985
Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor HJ Alsenz, T F Schulz, J D Lambris, et al.
Molecular Immunology|December 1, 1984
Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferationA Erdei, E Spaeth, J Alsenz, et al.
Pharmaceutical Research|September 16, 2000
Oral absorption of peptides through the cobalamin (vitamin B12) pathway in the rat intestineJ Alsenz, G J Russell-Jones, S Westwood, et al.
International Archives of Allergy and Applied Immunology|January 1, 1982
A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cellsO Scheiner, K P Hammann, H U Schmid, et al.
Immunobiology|August 1, 1983
Importance of factors H and I for the adherence of C3b-coated erythrocytes to cellsO Scheiner, T F Schulz, H U Schmid, et al.
European Journal of Immunology|November 1, 1991
Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21)I Esparza, J D Becherer, J Alsenz, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 1, 1997
Interferon immunogenicity: preclinical evaluation of interferon-alpha 2aA V Palleroni, A Aglione, M Labow, et al.
Developmental and Comparative Immunology|January 1, 1992
Phylogeny of the third component of complement, C3: analysis of the conservation of human CR1, CR2, H, and B binding sites, concanavalin A binding sites, and thiolester bond in the C3 from different speciesJ Alsenz, D Avila, H P Huemer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 18, 2021
UNGAP best practice for improving solubility data quality of orally administered drugsM Vertzoni, J Alsenz, P Augustijns, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Complement and Inflammation|January 1, 1989
Cell surface proteins reacting with activated complement componentsJ D Becherer, J Alsenz, C Servis, et al.
The Biochemical Journal|December 15, 1985
Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor HJ Alsenz, T F Schulz, J D Lambris, et al.
Molecular Immunology|December 1, 1984
Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferationA Erdei, E Spaeth, J Alsenz, et al.
Pharmaceutical Research|September 16, 2000
Oral absorption of peptides through the cobalamin (vitamin B12) pathway in the rat intestineJ Alsenz, G J Russell-Jones, S Westwood, et al.
International Archives of Allergy and Applied Immunology|January 1, 1982
A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cellsO Scheiner, K P Hammann, H U Schmid, et al.
Immunobiology|August 1, 1983
Importance of factors H and I for the adherence of C3b-coated erythrocytes to cellsO Scheiner, T F Schulz, H U Schmid, et al.
European Journal of Immunology|November 1, 1991
Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21)I Esparza, J D Becherer, J Alsenz, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 1, 1997
Interferon immunogenicity: preclinical evaluation of interferon-alpha 2aA V Palleroni, A Aglione, M Labow, et al.
Developmental and Comparative Immunology|January 1, 1992
Phylogeny of the third component of complement, C3: analysis of the conservation of human CR1, CR2, H, and B binding sites, concanavalin A binding sites, and thiolester bond in the C3 from different speciesJ Alsenz, D Avila, H P Huemer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 18, 2021
UNGAP best practice for improving solubility data quality of orally administered drugsM Vertzoni, J Alsenz, P Augustijns, et al.
Pageof 3